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The multifunctional protein E4 transcription factor 1 (E4F1) is an
essential regulator of epidermal stem cell (ESC) maintenance. Here,
we found that E4F1 transcriptionally regulates a metabolic pro-
gram involved in pyruvate metabolism that is required to maintain
skin homeostasis. E4F1 deficiency in basal keratinocytes resulted in
deregulated expression of dihydrolipoamide acetyltransferase (Dlat),
a gene encoding the E2 subunit of the mitochondrial pyruvate de-
hydrogenase (PDH) complex. Accordingly, E4f1 knock-out (KO) kera-
tinocytes exhibited impaired PDH activity and a redirection of the
glycolytic flux toward lactate production. The metabolic reprogram-
ming of E4f1 KO keratinocytes associated with remodeling of their
microenvironment and alterations of the basement membrane, led
to ESC mislocalization and exhaustion of the ESC pool. ShRNA-medi-
ated depletion of Dlat in primary keratinocytes recapitulated defects
observed upon E4f1 inactivation, including increased lactate secre-
tion, enhanced activity of extracellular matrix remodeling enzymes,
and impaired clonogenic potential. Altogether, our data reveal a
central role for Dlat in the metabolic program regulated by E4F1 in
basal keratinocytes and illustrate the importance of PDH activity in
skin homeostasis.
E4F1 | PDH | pyruvate | skin | stem cell
Renewal and wound healing of the epidermis rely on a pool ofepidermal stem cells (ESC) located in the basal layer of the
interfollicular epithelium (IFE) and in the bulge region of the
hair follicle (HF). In the IFE, these long-lived ESC give rise to
progenitors with increased proliferative capacities that differen-
tiate into keratinocytes as they migrate upward into suprabasal
layers. Numerous studies have addressed the role of several key
signaling pathways, such as those implicating bone morphoge-
netic proteins, TGF-β, Notch, Sonic Hedgehog, or Wnt in skin
homeostasis, and how they control ESC maintenance (1–3). The
role of these pathways in regulating stemness has been attributed
to the regulation of cell proliferation, cell death, cellular senes-
cence, cell adhesion, or differentiation. Although previous data
indicate that some of these stem cell regulators also control energy
metabolism in the hematopoietic or neuronal lineages (4), very few
studies have yet addressed their metabolic functions in keratino-
cytes. In addition, the potential role of specific metabolic regulators
in the control of skin homeostasis remains poorly documented.
Nevertheless, previous observations indicate that deregulation
of the nutrient-sensing mammalian target of rapamycin path-
way in basal keratinocytes occurs as a consequence of pro-
longed Wnt signaling, leading to the progressive exhaustion of
HF bulge stem cells (5). Recent data also indicate that genetic
inactivation in mouse epidermis of mitochondrial transcription
factor A (Tfam), a gene involved in mitochondrial DNA replication
and transcription, impinges on keratinocyte differentiation but
does not impair maintenance of basal keratinocytes (6). Al-
though these results suggest that basal keratinocytes display a
metabolic status that is different from their differentiated counter-
parts, further studies are warranted to decipher the poorly un-
derstood role of metabolism in the regulation of epidermal
cell fate.
We previously identified the multifunctional protein E4 tran-
scription factor 1 (E4F1) as an essential regulator of skin homeo-
stasis and ESC maintenance (7). E4F1 was originally identified as a
cellular target of the E1A viral oncoprotein (8, 9). Since then,
several laboratories have shown that E4F1 directly interacts with
several oncogenes and tumor suppressors, including p53, BMI1,
RB, RASSF1A, SMAD4, or HMGA2 proteins (10–16). Consistent
with its implication in different oncogenic pathways, E4F1 acts as
a survival factor in cancer cells (17, 18). Moreover, characterization
of E4f1 knock-out (KO) mice showed that E4f1 is an essential
gene in embryonic stem cells and during early embryogenesis (19).
Using E4f1 conditional KO mice, we previously reported that E4f1
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inactivation in the epidermis results in ESC defects through a
mechanism that involves, at least partly, the deregulation of the
Bmi1–Arf–p53 pathway (7). Here, we show evidence supporting
a major role for E4F1 in pyruvate metabolism that governs ESC
maintenance and skin homeostasis.
Results
E4f1 Inactivation in Basal but Not Suprabasal Adult Keratinocytes
Leads to Epidermal Defects and Exhaustion of the ESC Pool. Using
E4f1 whole-body conditional KO mice (E4f1KO; RERT), we
previously identified an essential role for E4f1 in adult skin ho-
meostasis (7). In this genetically engineered mouse model, E4f1
inactivation was achieved in the entire skin of adult animals,
including the dermal compartment. To assess the cell of origin of
these skin defects, we generated new mouse strains by crossing
E4f1 conditional KO mice to transgenic animals expressing the
tamoxifen (tam) -inducible CreER recombinase under the control
of the keratin 14 (K14) or keratin 10 (K10) promoters [hereafter
referred to as E4f1(K14)KO and E4f1(K10)KO strains], allowing
acute inactivation of E4f1 in adult keratinocytes of the basal or
spinous layers, respectively (20).
Molecular and histological analyses of adult back skin of 8- to
12-wk-old E4f1(K10)KO animals confirmed that topical skin
applications of tam activated the Cre recombinase in suprabasal
but not in basal keratinocytes (Fig. S1). Neither histological al-
terations nor differences in the expression pattern of the basal-
cell specific K14 marker and of the differentiation markers K10
and involucrin were identified in skin samples harvested up to
4 mo upon regular tam administration (Fig. S2). In sharp contrast,
inactivation of E4f1 in adult basal keratinocytes of E4f1(K14)KO
mice resulted in skin phenotypes that recapitulated those origi-
nally observed in tam-treated E4f1-/flox; RERT adult mice. Thus,
2 wk after tam administration, E4f1(K14)KO mice displayed
epidermal hyperplasia (acanthosis), altered differentiation
(dyskeratosis), and a thicker and parakeratotic cornified layer
(Fig. 1A and Fig. S3). Aberrant hyperproliferation andmislocalisation
of basal keratinocytes was evidenced in E4f1-deficient epidermis by
increased Ki67 staining, the presence of K14+ cells in suprabasal
layers, and the expression of keratin 6 (K6) in the IFE (Fig. S4). At
later time points (4–5 wk after tam administration), E4f1-deficient
epidermis then became hypocellular, whereas the hyperkeratosis
remained evident (Fig. 1A). In addition, impaired keratinocyte
differentiation was illustrated by aberrant expression of K10 and
involucrin (Fig. S4).
Consistent with our previous observations, ablation of E4f1 in
adult basal keratinocytes altered ESC function and resulted in
the definitive exhaustion of the ESC pool. Indeed, tam admin-
istration to E4f1(K14)KOmice led to the loss of expression of the
bulge HF stem cell marker keratin 15 (K15) (Fig. 1B). Flow
cytometry analysis of HF stem cells identified by the coex-
pression of CD34 and high levels of α6-integrin (CD34+/α6high)
confirmed that tam-treated E4f1(K14)KO adult epidermis con-
tained fewer HF stem cells compared with control epidermis
(0.65% ± 0.15 vs. 2.25% ± 0.4) (Fig. 1C). We also tracked ESCs in
the IFE by analyzing the number of label retaining cells (LRCs)
using an adaptation of an in vivo labeling protocol of multipotent
ESC based on the utilization of the nucleotide analog ethynyl-2′-
deoxyribose (EdU) (21). These analyses showed that E4f1 in-
activation resulted in a significant decrease in the number of LRCs
5 wk after tam administration, indicating that E4f1 deficiency led
to the definitive loss of ESC in vivo (Fig. 1D). Finally, E4f1KO
ESC defects were also illustrated ex-vivo by their impaired clo-
nogenic potential (Fig. 1E).
Thus, these data demonstrate that the epidermal hyperplasia,
hyperkeratosis, differentiation defects, and exhaustion of the
ESC pool of E4F1-deficient epidermis originate from alterations
in basal rather than suprabasal keratinocytes.
E4F1 Controls Pyruvate Metabolism in Keratinocytes Through Transcrip-
tional Regulation of the E2 Subunit of the Pyruvate Dehydrogenase
Complex Dlat. Using a pan-genome ChIP approach combined
with next-generation sequencing (ChIP-seq), we identified
E4F1 binding sites at the whole-genome level in primary mouse
embryonic fibroblasts and embryonic stem cells (18, 22). Func-
tional annotation of E4F1 direct target genes indicated a
significant enrichment in genes implicated in metabolism,
including a set of five genes encoding core components or
regulators of the mitochondrial pyruvate dehydrogenase (PDH)
complex (PDC), a multimeric complex that converts pyruvate
into Acetyl-CoA (AcCoA). In embryonic stem cells, this set of
E4F1-controlled genes includes the E2 and E3 subunits of the
PDC, dihydrolipoamide acetyltransferase (Dlat) and dihydrolipoyl
dehydrogenase (Dld), the regulatory subunit of the PDH phos-
phatase complex (Pdpr), the pyruvate transporter of the inner
mitochondrial membrane Brp44l/Mpc1 (23, 24), and the mito-
chondrial transporter Slc25a19 that transports the PDH cofactor
thiamine pyrophosphate (25). These results prompted us to eval-
uate whether E4F1 also controlled this set of PDH-related genes
in primary keratinocytes. First, we confirmed by quantitative ChIP
that endogenous E4F1 was recruited to the promoter of Dlat, Dld,
Slc25a19, and Brp44l in cultured primary murine keratinocytes
(Fig. 2A). Similarly to E4f1KO fibroblasts and muscle cells, E4F1-
deficient keratinocytes displayed a marked decrease of Dlat
mRNA level. However, the expression of Dld, Pdpr, Slc25a19, and
Brp44l/Mpc1 remained unchanged upon E4f1 inactivation, sug-
gesting that other E4F1-independent mechanisms contribute to
their expression in keratinocytes (Fig. 2B). The mRNA levels of
other PDH-related genes, including Pdha1, which encodes the E1
Fig. 1. E4F1 deficiency in basal keratinocytes leads to skin defects and ex-
haustion of the ESC pool. (A) Microphotographs of (HES)-stained skin sec-
tions prepared from E4F1(K14)KO mice or E4F1(K14)CTR littermates, 1, 2, or
5 wk after tam administration. Dashed lines indicate the separation between
the epidermis and the dermis. (Scale bars, 100 μm.) (B) Whole mounts of tail
epidermis prepared from adult E4F1(K14)KO and CTR mice, 5 wk after tam
application, stained with K15 antibody and DAPI. Brackets: bulge area (BG)
of the HF. (Scale bar, 100 μm.) (C) Number of follicular stem cells (FSC) in back
skin epidermis prepared from the same mice as in B. FACS-analysis of α6/CD34
CD34high FSC in back skin epidermis prepared from the samemice as in B (mean±
SEM; n = 10). (D) Number of label-retaining (EdU+) interfollicular stem cells (LRCs)
detected by immunofluorescence (IF) on back-skin sections prepared from adult
E4F1(K14)KO mice or E4F1(K14)CTR littemates, 5 wk after tam application.
Histobars represent the mean value ± SEM of EdU+ cells per millimeter of
epidermis (n = 5 animals per group). (E) Clonogenic assays performed with
E4F1KO and CTRL primary murine keratinocytes cultured in presence or absence
of 4OHT, as indicated (n = 5). Histobars represent the total number of clones per
well relative to control cells (expressed as percentages) determined after rho-
damine B staining. ***P < 0.001; **P < 0.01; ns, not significant.
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subunit of the PDC, the PDH -kinases 1/4 (Pdk1, Pdk4) and
-phosphatases 1/2 (Pdp1, Pdp2) remained unchanged in E4f1-
deficient keratinocytes (Fig. S5). Decreased Dlat expression was
confirmed at the protein level, as shown by immunostaining of
skin samples prepared from E4f1(K14)KO animals, 1 wk after
tam-administration. This decrease was further confirmed by im-
munoblotting both in tam-treated E4f1(K14)KO epidermis and in
cultured E4f1KO primary keratinocytes (Fig. 2 C–E). Consistent
with DLAT deregulation, altered PDH enzymatic activity was
detected in these cells (Fig. 2 F and G and Fig. S6A). Taken to-
gether, these data indicate that the E2 subunit of the PDCDlat is a
major direct transcriptional target of E4F1 in basal keratinocytes.
E4f1KO Results in Metabolic Reprogramming of Keratinocytes. Next,
we characterized the metabolic consequences of impaired PDH
activity in E4F1-deficient keratinocytes. We postulated that de-
creased PDH activity in E4F1-deficient keratinocytes triggered a
decrease of glucose-derived AcCoA production and the redirection
of the glycolytic flux toward lactate production (Fig. 3A). Consis-
tent with this hypothesis and the role of AcCoA as a donor sub-
strate for acetylation reactions, E4f1KO keratinocytes exhibited
decreased histone H4 acetylation, as shown by immunoblotting
using an anti-pan-acetyl lysine histone H4 antibody (Fig. 3B).
Moreover, in line with increased pyruvate metabolism by the
NADH-dependent lactate dehydrogenase (LDH), E4f1KO ker-
atinocytes displayed an increased NAD+/NADH ratio (Fig. 3C).
Increased expression of the glucose transporter GLUT1 suggested
that glucose uptake increased upon E4f1 inactivation in keratino-
cytes (Fig. S6B). These cells also exhibited increased expression of
the monocarboxylate transporter MCT4 that favors the efflux of
lactate outside the cell (Fig. 3 D and E). Accordingly, increased
lactate secretion by E4f1KO keratinocytes was evidenced by a
change in their extracellular acidification rate (ECAR) (Fig. 3F).
Other metabolic changes were observed in E4F1-deficient kerati-
nocytes, as illustrated by increased fatty acid oxidation (FAO) (Fig.
3G). This adaptative metabolic response was likely sufficient to
sustain mitochondrial respiration because no significant difference
was observed in oxygen consumption upon E4f1 inactivation in
keratinocytes cultured in complete medium (Fig. S6D). Analyses of
tam-treated E4f1(K14)KO mice and control littermates confirmed
that E4F1-deficient keratinocytes underwent the same metabolic
Fig. 2. E4f1 inactivation in basal keratinocytes results in decreased Dlat
expression and impaired PDH activity. (A) ChIP-qPCR assays performed with
anti-E4F1 or control (CTR) antibodies in cultured primary keratinocytes on
the promoter region of Dlat, Dld, Mpc1/brp44l, Pdpr, and Slc25a19. A gene-
poor noncoding region of chromosome 6 (NC2) and the Pdha1 promoter
region (TSS, transcription start site) were used as controls. Enrichments are
represented as percentages of input (mean value ± SEM; n = 3). (B) mRNA
levels of E4f1, Dlat, Dld, Brp44L/Mpc1, Pdpr and Slc25a19 in the epidermis of
E4f1(K14)KO mice or E4f1(K14)CTR littermates, 1 wk after tam administra-
tion. Histobars represent the mean value ± SEM (n = 5) determined by RT-
qPCR. (C and D) Protein levels of E4F1, DLAT, PDHA1, and β-actin (loading
control) determined by immunoblotting in (C) total protein extracts prepared
from epidermis of E4f1(K14)KO mice and control littermates, 1 wk after tam
administration, or (D) E4f1KO or CTRL cultured primary keratinocytes. #Non-
specific band. (E) Immunostaining of DLAT in skin sections prepared from the
samemice as in C. Sections were counterstained with DAPI. (Scale bar, 50 μm.) (F
andG) PDH activity measured in protein extracts prepared (F) from epidermis of
E4f1(K14)KO and CTR mice, 1 wk after tam administration, or (G) from cultured
primary keratinocytes of the indicated genotype using Colorimetric Assay kit
(Biovision) (mean ± SEM, n = 5). All analyses in cultured primary keratinocytes
were performed after 4 d of culture in the presence of 4OHT. ***P < 0.001;
**P < 0.01; *P < 0.05; ns, not significant.
Fig. 3. Metabolic reprogramming of E4F1-deficient keratinocytes. (A) Sche-
matic representation of the metabolic reprogramming in E4f1KO keratinocytes
including the redirection of the glycolytic flux toward lactate production. (B)
Protein levels of acetylated-lysine histone H4 and β-actin (loading control) de-
termined by immunoblotting in total protein extracts prepared from epidermis
of E4f1(K14)KO mice (Upper) or from E4f1KO cultured primary keratinocytes
(Lower) and match control (CTR) samples. (C) NAD+/NADH ratio in E4f1KO and
CTR cultured primary keratinocytes (mean ± SEM; n = 9). (D and E) MCT4 ex-
pression was determined by IF (D) and by immunoblotting (E) in E4f1KO and
CTR cultured primary keratinocytes. (Magnification: 40×.) (F) ECAR of E4f1KO
and CTR primary keratinocytes in basal conditions or after addition of glucose
(mean ± SEM; n = 5). (G) Relative level of FAO measured upon incubation of
E4f1KO and CTR cultured keratinocytes with 3H-palmitate (mean ± SEM of n =
5). (H) Immunohistochemistry analysis of MCT4 expression in skin sections pre-
pared from E4f1(K14)KO and CTR mice, 2 wk after 4OHT administration. (Scale
bar, 50 μm.) (I and J) Lactate (I) and ketone bodies (J) levels in the serum of E4f1
(K14)KO mice and CTR littermates, 1 wk after tam administration (n = 5 animals
per group). (K) Clonogenic assays performed with E4f1KO and CTR primary
keratinocytes in presence or absence or acetate, as indicated (n = 3). ***P <
0.001; **P < 0.01; *P < 0.05; ns, not significant. TCA, tricarboxylic acid cycle.
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reprogramming in vivo. Thus, immunohistochemistry (IHC) anal-
yses of skin samples prepared from these animals indicated that
E4f1 inactivation in basal keratinocytes resulted in increased ex-
pression of GLUT1, MCT4, and of CD147/BASIGIN, a chaperone
required for MCT4 relocalization at the cytoplasmic membrane
(Fig. 3H and Fig. S6C). Strikingly, E4f1(K14)KO mice exhibited
lactic acidemia and increased level of circulating ketone bodies, a
by-product of FAO (Fig. 3 I and J). Moreover, the clonogenic
potential of E4f1KO keratinocytes was partly rescued by addition
of exogenous acetate that can replenish AcCoA pools (Fig. 3K),
confirming that the profound metabolic reprogramming of E4F1-
deficient keratinocytes impinged on their biological functions.
Metabolic Reprogramming of E4F1-Deficient Keratinocytes Associates
with Remodeling of the Microenvironment and Loss of Adhesion of
the ESC with the Basement Membrane. In many tumors, increased
lactate secretion has been linked to the remodeling of the ex-
tracellular matrix (ECM) and degradation of the basement
membrane (BM) by ECM-remodeling enzymes (26). To further
characterize the consequences of the metabolic reprogramming of
E4F1-deficient keratinocytes, we performed histological analyses
of E4f1(K14)KO skin. Electron microscopy analyses indicated that
E4f1 inactivation in basal keratinocytes resulted in disorganization
of the BM, which appeared either diffused with thinner lamina
densa or focally disrupted (Fig. S7A). Alterations of the BM in
E4f1KO skin was confirmed upon staining of skin sections by the
Gomori reticulin method, which stains the argyrophilic (silver
staining) fibrous structures present in the BM (Fig. S7B). Immu-
nostaining of skin samples prepared from E4f1(K14)KOmice with
anti-laminin V antibody showed that the expression pattern of this
essential component of the BM was diffused and focally discon-
tinuous in E4f1KO skin sections compared with its defined and
continuous pattern in control samples (Fig. 4A). This defect also
correlated with an abnormal expression pattern of integrin β4
(Itgβ4). In areas showing broad disruption of the BM, Itgβ4
expression was not restricted to the basal pole of keratinocytes but
was also detected at the apical or lateral sides of both basal and
suprabasal keratinocytes (Fig. 4A). Remodeling of the ECM
within the dermal compartment was also evidenced by picro-Sirius
red staining of collagen fibers on skin sections prepared from tam-
treated E4f1(K14)KO mice (Fig. S7C). These results led us to
investigate whether the massive remodeling of the ECM and al-
terations of the BM observed upon E4f1 inactivation resulted from
increased activity of ECM-remodeling enzymes. Increased matrix
metallopeptidase 9 (MMP9) and cathepsin activities were de-
tected by gelatin-zymography in protein extracts prepared from
total skin samples of tam-treated E4f1(K14)KO mice (Fig. 4B and
Fig. S7D). Moreover, increased MMP2, MMP9, and cathepsin
activities were also evidenced in the culture medium of E4f1KO
primary keratinocytes (Fig. 4 C and D). Addition of the LDH-
inhibitor oxamate in the culture medium decreased cathepsin
activities, confirming that their induction resulted from the met-
abolic reprogramming of these cells (Fig. 4D). Moreover, stable
expression of ectopic TIMP1, a broad MMP inhibitor, in feeder
cells partly rescued the clonogenic potential of E4f1KO ESC (Fig.
4E). Improved clonogenicity of E4F1-deficient ESC was also ob-
served upon incubation with GM6001, a pharmacological MMP
inhibitor with broad spectrum (Fig. 4F). Taken together, these
data indicate that the induction of ECM remodeling enzymes in
E4F1-deficient keratinocytes is a consequence of their metabolic
reprogramming and impinges on their clonogenic potential.
Based on these results, we hypothesized that the observed
disruption of the BM impacted on the maintenance of ESC
within their normal microenvironment, leading to the definitive
exhaustion of the ESC pool. To test this hypothesis, we analyzed
EdU+ LRCs on skin sections prepared from E4f1(K14)KO mice
or control littermates 2 wk after tam administration and evalu-
ated their localization within the epidermis. The same skin sec-
tions were also processed to assess MCT4 expression as a
surrogate marker of the metabolic reprogramming of E4f1KO
Fig. 4. E4f1 inactivation in basal keratinocytes re-
sults in alterations of the BM, remodeling of the
ECM and ESC mislocalization. (A) IF analysis of Lam-
inin V (LamV, red) and Intβ4 (green) expression in
skin sections prepared from E4f1(K14)KO and CTR
mice, 2 wk after tam administration. Sections were
counterstained with DAPI (blue). (Scale bars, 50 μm.)
(B, Left) Representative zymogel analysis of MMP
activities in protein extracts prepared from skin
samples of E4f1(K14)KO and CTR mice, 2 wk after
tam administration. For normalization, β-actin im-
munoblotting was performed on the same protein
extracts. (Right) Quantification of MMP2 and MMP9
activities (mean ± SEM, n = 5 animals per group).
(C, Left) MMP activities measured by zymography in
conditioned media (CM) from E4f1KO or CTR cul-
tured primary keratinocytes. For normalization,
β-actin expression was analyzed by immunoblotting
in protein extracts prepared from the same cells.
(Right) Quantification of MMP2 and MMP9 activities
(mean ± SEM, n = 4). (D, Left) Cathepsin activities
measured by zymogel in CM from E4f1KO or CTR
primary keratinocytes cultured in the presence or
absence of oxamate. (Right) Quantification of ca-
thepsin activities (mean ± SEM, n = 3). (E) Clonogenic
assays performed with E4f1KO and CTR primary
keratinocytes in presence of feeders transduced with
empty or TIMP1-encoding retroviruses (mean ± SEM;
n = 9). (F) Clonogenic assays performed with E4f1KO and CTR primary keratinocytes in presence or absence or the MMP-inhibitor GM6001 (mean ± SEM; n =
6). (G) Mislocalization of E4f1KO ESC. LRCs were identified by IF on skin sections prepared from E4f1(K14)KO and CTR mice, 2 wk after tam administration.
MCT4 costaining was performed to identify metabolically reprogrammed cells. Sections were counterstained with DAPI. (Scale bar, 30 μm.) Arrows indicate
EdU+ LRCs. Histobars represent the total number of EdU+ LRCs per millimeter of epidermis and their respective localization in the basal or suprabasal (SB)
layers (mean ± SEM, n = 4 animals per group). ***P < 0.001; **P < 0.01; *P < 0.05; ns, not significant.
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keratinocytes. Two weeks after tam administration, E4f1KO
epidermis displayed approximately the same number of EdU+
LRCs than control epidermis (0.25 ± 0.05 vs. 0.23 ± 0.02 per
millimeter, respectively). However, the number of E4f1KO LRCs
in a suprabasal position was significantly increased compared
with LRCs of control epidermis that remained, as expected, in
the basal layer (suprabasal: 0.1 ± 0.04 vs. 0.01 ± 0.01; basal: 0.14 ±
0.03 vs. 0.21 ± 0.003 per millimeter, respectively) (Fig. 4G).
Interestingly, this atypical feature of E4f1KO LRCs was par-
ticularly evident within focal epidermal lesions exhibiting MCT4
positivity, whereas LRCs remained in contact with the BM in
the adjacent MCT4− areas of the same epidermis (Fig. 4G). Five
weeks after tam administration, the number of LRC diminished
in E4f1KO epidermis, confirming that E4f1 inactivation finally
ended in the exhaustion of the ESC pool (Fig. 1D). Thus, these
data show that the metabolic reprogramming triggered by E4f1
inactivation in basal keratinocytes associates with the remodel-
ing of their microenvironment and alterations of the BM,
leading to the loss of attachment of the ESC within their normal
niche and their definitive loss.
DLAT Is a Central Component of the E4F1-Regulated Metabolic
Program in Basal Keratinocytes. Because Dlat appeared as one of
the most deregulated E4F1 target gene in the epidermis of tam-
treated E4f1(K14)KO animals, we evaluated the consequences of
shRNA-mediated depletion of Dlat in primary keratinocytes.
Lentiviral-mediated delivery of shRNAs targeting Dlat in pop-
ulations of primary murine keratinocytes led to an expected
decrease of DLAT protein level and PDH activity (Fig. 5A and
Fig. S8A) and induced phenotypes that were reminiscent of those
observed in E4f1KO keratinocytes. Thus, DLAT depletion in
primary keratinocytes resulted in their metabolic reprogram-
ming, as illustrated by increased MCT4 expression, and in-
creased MMP2, MMP9, and cathepsin activities (Fig. 5 B and C
and Fig. S8 B and C). Furthermore, similarly to E4F1-deficient
ESC, DLAT-depleted keratinocytes also displayed an alteration
of their clonogenic potential (Fig. 5D). Taken together, these
data strengthen the role of DLAT as a central component of
E4F1-regulated metabolic program in primary keratinocytes.
Discussion
Our analyses performed in different mouse models where E4f1
was genetically inactivated in the basal or the spinous layers of
the epidermis show that the complex skin phenotypes observed
upon E4f1 inactivation originate from defects in basal kerati-
nocytes. Our results indicate that E4F1 deficiency in these cells
leads to a metabolic reprogramming of keratinocytes that affects
skin homeostasis and ended in the definitive exhaustion of the
ESC pool. We found that this metabolic shift, which includes the
redirection of the glycolytic flux toward lactate production, is a
direct consequence of PDH deficiency. Moreover, our data iden-
tify DLAT, the E2 subunit of the PDC, as an essential component
of this metabolic program regulated by E4F1 in keratinocytes.
Whether E4F1-mediated control of the PDC in keratinocytes
is clinically relevant remains to be determined. It is worth noting,
however, that a homozygous nonsynonymous mutation in the
coding region of the E4f1 gene has been recently identified in a
patient presenting clinical symptoms resembling those of Leigh
syndrome patients (27). Although skin abnormalities have been
reported only in some Leigh syndrome patients (28), they are part
of the broad spectrum of clinical manifestations that are com-
monly observed in several mitochondrial disorders (29). Further
investigations are necessary to evalutate whether E4F1-mediated
control of mitochondrial activities, which likely extend beyond the
control of the PDC, contribute to the skin manifestations observed
in these patients.
Another pathological situation that has been associated with
changes in PDH activity is cancer. Interestingly, the metabolic
rewiring of E4f1KO keratinocytes is reminiscent of the one ob-
served in many cancer cells that display increased aerobic glycol-
ysis, even in high oxygen conditions, an effect known as the
Warburg effect. It is well established that PDH deregulation in
cancer cells can result from posttranslational modifications of PDC
subunits by inhibitory kinases (PDKs), activating phosphatases
(PDPs), or the lipoamidase SIRT4 (30, 31). We failed to detect
deregulation of Pdks and Pdps mRNA levels in E4f1KO kerati-
nocytes, and our data rather support the notion that transcriptional
control of Dlat is the main mechanism by which E4F1 controls
PDH activity in normal epidermal cells. It remains to be seen
whether E4F1-mediated control ofDlat is an alternative regulatory
mechanism of the PDC in skin cancer cells. Nevertheless, our data
clearly show that the control of PDH activity by E4F1 in basal
keratinocytes is essential for normal skin homeostasis.
Interestingly, as with cancer cells, we show that the metabolic
reprogramming of E4f1KO basal keratinocytes results in increased
activity of ECM-remodeling enzymes, including MMPs and ca-
thepsins. The exact molecular mechanism by which increased gly-
colysis activates MMP activity in cancer cells remains controversial.
Previous studies have suggested that the MCT-chaperone CD147/
BASIGIN increases MMP activity through a yet undefined mech-
anism (32). However, recent data contradict this working model
(33). Whatever the mechanism, the high glycolytic profile and in-
creased activity of tissue-remodeling enzymes of fully transformed
cells have been associated with their increased migratory and in-
vasive properties that contribute to metastatic dissemination. Our
data show that the metabolic reprogramming of normal E4f1KO
keratinocytes recapitulates some features of cancer cells, including
their ability to induce the focal degradation of the basement
membrane and to remodel their microenvironment. Here, we show
that these alterations impact on ESC maintenance within their
niche, leading to their mechanical elimination and ending in the
complete exhaustion of the ESC pool. Interestingly, we previously
reported that the ability of E4F1 to control the Bmi1–ARF–p53
pathway partly contributes to ESC self-renewal (7). These data
raise interesting questions regarding the connection between the
metabolic reprogramming of E4F1-deficient keratinocytes and the
deregulation of the p53 pathway in these cells. The potential cross-
talk between PDH activity and the control of the p53 pathway is a
promising hypothesis that warrants further investigation.
Fig. 5. DLAT depletion in primary murine keratinocytes results in their
metabolic reprogramming, increased MMP activity and ESC defects. (A) DLAT
and ACTIN (loading control) expression determined by immunoblotting in
total protein extracts prepared from murine primary keratinocytes trans-
duced with lentiviruses encoding control or Dlat ShRNAs. (B) IF analysis of
MCT4 expression in murine primary keratinocytes expressing control or Dlat
ShRNAs. (Magnification: 40×.) (C, Left) MMP activities measured by zymogel
in CM from primary keratinocytes expressing control or Dlat ShRNAs. (Right)
Quantification of MMP2 and MMP9 activities (mean ± SEM, n = 3). (D) Clo-
nogenic assays performed with primary murine keratinocytes expressing
control or Dlat ShRNAs (mean value ± SEM; n = 5).
11008 | www.pnas.org/cgi/doi/10.1073/pnas.1602751113 Goguet-Rubio et al.
It was recently proposed that basal keratinocytes rely more on
glycolysis to sustain their energetic demand than their differen-
tiated progeny in which mitochondrial-reactive oxygen species
trigger epidermal differentiation through Notch and β-catenin
signaling (6). Our data do not necessarily contradict this model,
but provide clear evidence that when glycolysis is further in-
creased in basal keratinocytes, such as in E4F1-deficient cells,
this profoundly alters epidermal homeostasis and ESC mainte-
nance. Our results also question the mechanisms leading to the
inhibition of keratinocyte differentiation observed in E4f1KO
epidermis.
Altogether our results identify E4F1 as an essential regulator
of the metabolic status of basal keratinocytes and stress the
importance of a tight control of the PDH activity for epidermal
homeostasis.
Materials and Methods
Generation of Mouse Models and Experimental Treatment. Generation of E4f1
KO and E4f1 cKO mice was previously described (7, 19). These mice were
intercrossed with K14CreER (20) or K10CreERT2 mice to generate experi-
mental groups (E4f1+/flox; K14CreER, E4f1−/flox; K14CreER, E4f1+/flox; K10CreERT2,
and E4f1−/flox;K14CreERT2 [referred as to E4F1(K14)CTR, E4F1(K14)KO, E4F1(K10)CTR,
E4F1(K10)KO, respectively]. Compound mice were maintained on a mixed genetic
background (129Sv/J/DBA/C57BL/6) and housed in a pathogen-free barrier
facility. Cre-mediated recombination of the E4f1flox allele was induced by topical
applications of tamoxifen (Sigma; diluted in ethanol, 2 mg/d for 4 consecutive
days) on shaved back or tail skin of 8- to 12-wk-old animals. Experiments
were approved by the regional ethics committee for animal welfare (Comité
éthique pour l’expérimentation animale du Languedoc Roussillon, protocol
12068). Oligonucleotides used for genotyping these animals are provided as in
SI Materials and Methods.
Histology, IHC, and Immunolabeling of Skin Sections. IHC and immunolabeling
of skin sections were performed as previously described (7) using the
following antibodies: anti-DLAT (sc-32925 Santa Cruz), MCT4 (sc-50329 Santa
Cruz), BASIGIN (G-19 sc-9757, Santa Cruz), Laminin V (generous gift from
C. Feral’s laboratory, University of Nice, Nice, France), Intβ4 (553745 BD
Pharmingen), K14 (PRB-155P (Covance), K10 (PRB-159P Covance), Involucrin
(sc-15230 Santa Cruz).
Culture of Primary Keratinocytes.Murine primary keratinocytes were isolated
from newborn skin as previously described (7) and grown in calcium-free
Eagle’s MEM (Bio-Whittaker; Lonza) supplemented with 8% (vol/vol) cal-
cium-free FBS (Sigma). Cre-mediated recombination was achieved by adding
4-hydroxy Tamoxifen (4OHT, Sigma; 1 μM final) to the culture medium.
Lactate, Ketone Bodies, and PDH Activity Measurement. Lactate and ketone
bodies concentration were measured from tail blood samples using a lac-
tometer (EKF Diagnostics) and β-ketone strips (Optium, Abbott). PDH activity
was measured with PDH Enzyme Activity Dipstick Assay Kit (Abcam) and PDH
Activity Colorimetric Assay kit (Biovision) according to the manufacturers’
recommendations.
Statistic Analyses. The unpaired Student’s t test was used in all analyses. Sta-
tistical significance was expressed as follows: *P < 0.05, **P < 0.01, ***P < 0.001.
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